AFM13
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for AFM13, covering 2013-06-26 to 2025-09-30. Get the full timeline:
Most recent: Clinical Trial Update: Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas [Phase 1, Phase 2]